second-line相关论文
...
Objective: Several studies have demonstrated different benefits for patients whose disease progressed despite previous t......
Second-line panitumumab as a triweekly dose for patients with wild-typeKRAS exon 2 metastatic colore
Objective: Panitumumab administered as monotherapy in colorectal cancer (CRC) has shown response and disease stabilizati......
目的：比较拓扑替康联合顺铂方案与IEP方案治疗复发性小细胞肺癌的疗效和不良反应。方法：80例复发性小细胞肺癌中,37例应用拓扑替康-D......
背景与目的：小细胞肺癌（small cell lung cancer,SCLC）一线化疗疗效较好,然而一旦复发,治疗十分困难,目前尚未确定最佳二线化疗方案。......
目的：回顾性分析两种不同化疗方案对一线化疗失败的晚期胃癌患者进行解救治疗的疗效和安全性，探讨晚期胃癌二线治疗适宜的化疗方案。......
